Evidence map›Paper›PMID 18287538›Full record

ArticleMolecular biology of the cell2008

Bap31 is an itinerant protein that moves between the peripheral endoplasmic reticulum (ER) and a juxtanuclear compartment related to ER-associated Degradation.

Yuichi Wakana, Sawako Takai, Ken-Ichi Nakajima, Katsuko Tani, Akitsugu Yamamoto, Peter Watson, David J Stephens, Hans-Peter Hauri, Mitsuo Tagaya

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. An X-Linked Ataxia Syndrome in a Family with Hearing Loss Associated with a Novel Variant in the BCAP31 Gene.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Case Report: The first Korean familial case ofFrontiers in pediatrics · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Yuichi WakanaSchool of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.
Sawako Takai
Ken-Ichi Nakajima
Katsuko Tani
Akitsugu Yamamoto
Peter Watson
David J Stephens
Hans-Peter Hauri
Mitsuo Tagaya
Tokyo University of Pharmacy and Life Sciences · JPGènes, synapses et cognition · FRNagahama Institute of Bio-Science and Technology · JPUniversity of Basel · CHUniversity of Bristol · GB

Funding

Medical Research Council G117/554Medical Research Council G117/554(71630)
6 · The paper itself

Abstract

Certain endoplasmic reticulum (ER)-associated degradation (ERAD) substrates with transmembrane domains are segregated from other ER proteins and sorted into a juxtanuclear subcompartment, known as the ER quality control compartment. Bap31 is an ER protein with three transmembrane domains, and it is assumed to be a cargo receptor for ER export of some transmembrane proteins, especially those prone to ERAD. Here, we show that Bap31 is a component of the ER quality control compartment and that it moves between the peripheral ER and a juxtanuclear ER or ER-related compartment distinct from the conventional ER-Golgi intermediate compartment. The third and second transmembrane domains of Bap31 are principally responsible for the movement to and recycling from the juxtanuclear region, respectively. This cycling was blocked by depolymerization of microtubules and disruption of dynein-dynactin function. Overexpression of Sar1p and Arf1 mutants affected Bap31 cycling, suggesting that this cycling pathway is related to the conventional vesicular transport pathways.

Indexed as

Cell CompartmentationProtein Processing, Post-TranslationalADP-Ribosylation Factor 1Brefeldin ACell LineEndoplasmic ReticulumGolgi ApparatusHumansIsoquinolinesMannose-Binding LectinsMembrane ProteinsMutationProtein Structure, TertiaryProtein TransportRecombinant Fusion ProteinsSulfonamidesADP-Ribosylation Factor 1BCAP31 protein, humanBrefeldin ADERL1 protein, humanIsoquinolinesLMAN1 protein, humanMannose-Binding LectinsMembrane ProteinsN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideRecombinant Fusion ProteinsSulfonamides

Identifiers

PMID18287538
PMCPMC2366873
OpenAlexW2136802921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.